0001179110-14-013492.txt : 20140902 0001179110-14-013492.hdr.sgml : 20140901 20140902204142 ACCESSION NUMBER: 0001179110-14-013492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140828 FILED AS OF DATE: 20140902 DATE AS OF CHANGE: 20140902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pacira Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001396814 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510619477 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 SYLVAN WAY STREET 2: SUITE 300 CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-254-3560 MAIL ADDRESS: STREET 1: 5 SYLVAN WAY STREET 2: SUITE 300 CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: PACIRA INC DATE OF NAME CHANGE: 20080318 FORMER COMPANY: FORMER CONFORMED NAME: Blue Acquisition Corp DATE OF NAME CHANGE: 20070418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wicki Andreas CENTRAL INDEX KEY: 0001511472 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35060 FILM NUMBER: 141078744 MAIL ADDRESS: STREET 1: C/O HBM BIOVENTURES (CAYMAN) LTD. STREET 2: CENTENNIAL TOWERS,STE.305,2454 W.BAY RD. CITY: GRAND CAYMAN STATE: E9 ZIP: E9 4 1 edgar.xml FORM 4 - X0306 4 2014-08-28 0 0001396814 Pacira Pharmaceuticals, Inc. PCRX 0001511472 Wicki Andreas GOVERNORS SQUARE, SUITE 4-212-2, 23 LIME TREE BAY AVE. WEST BAY GRAND CAYMAN E9 00000 CAYMAN ISLANDS 1 0 0 0 Common Stock 2014-08-28 4 S 0 11013 108.0629 D 1110581 I See footnote. Common Stock 2014-08-29 4 S 0 10481 108.1538 D 1100100 I See footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.00 to $108.28 inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote one (1) of this Form 4. The Board of Directors of HBM (the "HBM Board") has sole voting and investment power with respect to the securities held by such entity and acts by majority vote. The reporting person does not have sole voting or investment power over the securities held by HBM. However, the reporting person may be deemed to have beneficial ownership of these securities by virtue of his membership on the HBM Board. The reporting person disclaims beneficial ownership of the securities reported herein for the purposes of Rule 16a-1 (a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest herein, if any. This report on Form 4 shall not be deemed an admission that the reporting person is a beneficial owner for the purposes of Section 16 of the Exchange Act, or for any other purpose of Section 16 of the Exchange Act, or for any other purpose. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.00 to $108.58 inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote three (3) of this Form 4. /s/ Mehdi Khodadad (Attorney-in-Fact) 2014-09-02